Microneedle Patch With Botulinum Toxin in Management of Enlarged Facial Pores

Phase 3Active Not RecruitingNCT06293755

Dhurakij Pundit University16 enrolled

Overview

The purpose of this study is to assess the efficacy and safety of microneedle patch with botulinum toxin for improving enlarged pores.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Enlarged Pores

Interventions

Microneedle patchDEVICE

with 20 units botulinum toxin

Intradermal injectionDEVICE

with 20 units botulinum toxin

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * At least 18 years old and concerned about enlarged pores * Have pore size 0.3-0.6 mm * Have pore parameter in each other side of faces not different more than 5% Exclusion Criteria: * Any neuromuscular condition * Pregnancy or breast feeding * History of allergy : Botulinum toxin, topical anesthesia * History of keloid or hypertrophic scar * History of coagulation or receiving medication that causes coagulation disorder * Using drugs that have interaction with Botulinum toxin * Using topical medication that improves enlarged pores in 1 month * Taking medication that improves enlarged pores in 1 month * Receiving the laser/treatment/chemical peeling in 6 months

Locations (1)

Dhurakij Pundit University

Lak Si, Bangkok, Thailand

Outcomes

Primary Outcomes

Change from baseline of enlarged pores as measured by VISIA (pores parameter) and using pore score

the used pore scores, patients with visible pores took the score "1," and those with enlarged pores took "2." When black heads were embedded on facial pores the score was "3." The scores were assessed by 2 investigators who were blinded to the treatment used on each side.

Time frame: Post-intervention, week 4 and week 16

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.